Regulus Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Jan 24 | SellUS$6,510 | Crispina Calsada | Individual | 5,468 | US$1.19 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 17 | 0.000026% |
Individual Insiders | 1,096,572 | 1.68% |
Institutions | 10,052,320 | 15.4% |
VC/PE Firms | 22,817,341 | 34.9% |
General Public | 31,499,001 | 48.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 288.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,827,339 | US$15.4m | 0% | 0.51% | |||
6,250,000 | US$14.1m | 0% | 0.18% | |||
5,000,000 | US$11.3m | 0% | 0.86% | |||
4,740,002 | US$10.7m | 144% | 0.56% | |||
3,875,578 | US$8.8m | 0% | 0.02% | |||
2,922,600 | US$6.6m | 0% | no data | |||
1,155,516 | US$2.6m | 35.9% | no data | |||
1,111,049 | US$2.5m | 0% | 0.58% | |||
978,388 | US$2.2m | 34.3% | no data | |||
286,431 | US$647.3k | 0.48% | no data | |||
185,183 | US$418.5k | 0% | 0.08% | |||
178,404 | US$403.2k | 0% | 0.38% | |||
122,521 | US$276.9k | 0% | no data | |||
57,112 | US$129.1k | 37% | no data | |||
54,600 | US$123.4k | 8.98% | no data | |||
41,719 | US$94.3k | 0% | no data | |||
40,260 | US$91.0k | 0% | 0.01% | |||
39,056 | US$88.3k | 0% | no data | |||
28,461 | US$64.3k | 143% | no data | |||
17,978 | US$40.6k | 0% | no data | |||
17,500 | US$39.5k | 0% | no data | |||
10,264 | US$23.2k | -1.5% | no data | |||
10,056 | US$22.7k | 135% | no data | |||
4,733 | US$10.7k | 0% | no data | |||
2,740 | US$6.2k | 0% | no data |